EuroPCR 23: EBC MAIN Three-Year Follow Up

Join us as we discover the latest findings from a three-year follow-up of the EBC MAIN Trial, as we interview Principal Investigator Dr David Hildick-Smith (Brighton and Sussex University Hospitals, UK) onsite at EuroPCR 23.
The EBC Main Trial aimed to investigate the outcomes of single-stent versus dual-stent bifurcation treatment of distal left main coronary artery lesions. This study followed this patient population of 450 for three years.
Questions:
-What is the importance of the EBC Main study?
-What was the study design and patient population?
-How were operator experience and expertise accounted for in the trial?
-What are the main findings?
-What are the take home messages?
-What are the next steps?
Recorded on-site at EuroPCR 2023 in Paris.
Visit Radcliffe Cardiology: www.radcliffecardiology.com/
Visit Radcliffe Vascular: www.radcliffevascular.com/
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.
Like us on Facebook: / radcliffecardiology
Follow us on X: x.com/radcliffeCARDIO